CR Bard Inc (BCR)

BCR (NYSE:Health Services) EQUITY
$171.06
pos +0.00
+0.00%
Today's Range: 169.16 - 172.00 | BCR Avg Daily Volume: 597,100
Last Update: 04/17/15 - 4:01 PM EDT
Volume: 0
YTD Performance: 2.66%
Open: $0.00
Previous Close: $170.87
52 Week Range: $132.81 - $180.35
Oustanding Shares: 74,261,164
Market Cap: 12,700,073,197
6-Month Chart
TheStreet Ratings Grade for BCR
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 1 1 1 1
Moderate Buy 1 1 1 1
Hold 11 11 11 9
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 1
Mean Rec. 2.86 2.86 2.86 3.00
Latest Dividend: 0.22
Latest Dividend Yield: 0.52%
Dividend Ex-Date: 04/23/15
Price Earnings Ratio: 45.44
Price Earnings Comparisons:
BCR Sector Avg. S&P 500
45.44 44.70 27.96
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-1.72% 22.63% 74.52%
GROWTH 12 Mo 3 Yr CAGR
Revenue 9.00 0.15 0.05
Net Income -57.30 -0.10 -0.03
EPS -55.30 0.02 0.01
Earnings for BCR:
EBITDA 0.96B
Revenue 3.32B
Average Earnings Estimates
Qtr (03/15) Qtr (06/15) FY (12/15) FY (12/16)
Average Estimate $2.07 $2.17 $9.00 $9.95
Number of Analysts 12 11 14 12
High Estimate $2.11 $2.21 $9.03 $10.11
Low Estimate $2.05 $2.12 $8.96 $9.80
Prior Year $1.91 $2.06 $8.40 $9.00
Growth Rate (Year over Year) 8.42% 5.52% 7.11% 10.55%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Dick Arms

 | Feb 26, 2015 | 7:00 AM EST

Traders should be looking for shorting opportunities.

bullishCR Bard upgraded at JP Morgan

Jan 20, 2015 | 7:30 AM EST

BCR was upgraded from Underweight to Neutral, JP Morgan said. Lutonix and drug-coated ballons could exceed expectations. 

bearishCR Bard downgraded at JP Morgan

Jan 5, 2015 | 7:51 AM EST

BCR was downgraded from Neutral to Underweight, JP Morgan said. Valuation call, based on a $162 price target. 

bullishCR Bard upgraded at Morgan Stanley

Jan 5, 2015 | 6:43 AM EST

BCR was upgraded to Equal-weight from Underweight, Morgan Stanley said. $187 price target. Company has significant earnings flexibility. 

By

Jim Cramer

 | Dec 15, 2014 | 7:08 AM EST

Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.

By

Bret Jensen

 | Dec 12, 2014 | 8:37 AM EST
Though broad futures have improved somewhat.
By

Jim Cramer

 | Nov 17, 2014 | 4:33 AM EST

There's a powerful collection of "what's working."

By

John Reese

 | Oct 11, 2014 | 10:30 AM EDT

These stocks are all worth your consideration.

By

Jim Cramer

 | Jul 7, 2014 | 11:18 AM EDT

A wave of M&A in the health sector makes sense.

bearishCR Bard downgraded at BofA/Merrill

Apr 7, 2014 | 8:19 AM EDT

BCR was downgraded from Buy to Neutral, Bank of America/Merrill Lynch said. Valuation call, based on a $150 price target. 

El Polo Loco Holding (LOCO) has been trading for less than a year and on the weekly timefr...
I am a proud new owner of an Apple Watch...sort of. While technically I own an Apple Watc...
Last Thursday I gave a webinar talking about a rare price condition called the 'fat tail',...

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.